April 16, 2025
Intangible Assets

Amazon cancels some inventory orders from China after tariffs

Spencer Soper  |  Bloomberg Amazon.com Inc. has canceled orders for multiple products made in China and other Asian countries, according to a document reviewed by Bloomberg and people familiar with the matter, suggesting the company is reducing its exposure to tariffs imposed by President Donald Trump. The orders for beach chairs, scooters, air conditioners and

Read More
Intangible Assets

Network-1 Announces Acquisition of Patent Portfolio

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Network-1 Technologies, Inc. (NYSE American:NTIP), a company engaged in the acquisition, development, licensing and monetization of intellectual property, today announced the acquisition of a patent portfolio relating to several key advanced security technologies. The acquired portfolio includes eight (8) issued United States patents and

Read More
Intangible Assets

Green Bay area grocery stores prepare for 2025 NFL draft

Seven things to know about the 2025 NFL draft in Green Bay Here are a few things to know about the 2025 NFL draft being held April 24-26 in Green Bay. Green Bay grocery stores are increasing inventory and adjusting delivery schedules in anticipation of the 2025 NFL draft. Metro Market, located near the draft

Read More
Operating Assets

Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights

– Three INDs cleared by US FDA for TYRA’s proprietary precision small molecules – – TYRA-300 to be evaluated in three Phase 2 studies: SURF302 for Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC), BEACH301 for pediatric achondroplasia (ACH) and SURF301 for metastatic urothelial cancer (mUC) – – Cash, cash equivalents, and marketable securities of

Read More
Operating Assets

Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates

Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development to show benefit in patients with chronic cough in idiopathic pulmonary fibrosis (IPF) and RCC Completed enrollment in the Phase 2b CORAL trial in IPF patients with chronic cough in

Read More
Operating Assets

Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials in second half of 2025 Strong balance sheet with $313 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into mid-2027 BOULDER, Colo., Mar. 13, 2025

Read More
Operating Assets

ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) — ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company’s business. These included, first, the sale of

Read More
Fixed Assets

Trimble Announces SMS Equipment As First Trimble Technology Outlet Globally

Canadian Equipment Dealer Now Sells Trimble Grade Control Solutions for Komatsu, BOMAG and Takeuchi Equipment WESTMINSTER, Colo., March 10, 2025 /PRNewswire/ — Trimble® (Nasdaq: TRMB) today announced SMS Equipment, Inc. as the first Trimble Technology Outlet worldwide. As a Trimble Technology Outlet, SMS Equipment will now sell Trimble grade control, site positioning systems and correction

Read More
Intangible Assets

Distribution Solutions Group Announces 2024 Full Year and Fourth Quarter Results

Full Year Revenue Up 14.9% to $1.80B; Fourth Quarter Organic Sales Growth Drives Strong Cash Flow FORT WORTH, Texas, March 06, 2025–(BUSINESS WIRE)–Distribution Solutions Group, Inc. (NASDAQ:DSGR) (“DSG” or the “Company”), a premier specialty distribution company, today announced consolidated results for the full year and fourth quarter ended December 31, 2024. This press release is

Read More
Operating Assets

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

New data from the Phase 1/1b ARC-20 study showed that casdatifan improved upon the rate of primary progression, overall response rate (ORR) and progression-free survival (PFS) relative to published data from studies with HIF-2a inhibitors to date Initiation of the Phase 3 study for PEAK-1 evaluating casdatifan in combination with cabozantinib versus cabozantinib in immuno-oncology

Read More